Could milk-derived nanoparticles change bile-duct cancer care? | Tomorrows Cure Season 5 Episode 4 @MayoClinic
Could milk-derived nanoparticles change bile-duct cancer care? | Tomorrows Cure Season 5 Episode 4  @MayoClinic
Uploaded July 2026 | Updated September 2026, 2 weeks ago
On this episode of Tomorrow's Cure, we sit down with Dr. Rory L. Smoot, a hepatobiliary and pancreas surgeon at Mayo Clinic, and Melinda Bachini, a cholangiocarcinoma survivor and Chief Patient Officer and Director of Patient Services at the Cholangiocarcinoma Foundation. Together, they discuss this emerging area of research and how innovation, advocacy, and new treatment approaches are helping shape the future of care for this challenging disease.
Could milk-derived nanoparticles change bile-duct cancer care? | Tomorrows Cure Season 5 Episode 4Teachers connect beyond the classroom through paired kidney donationThe Mindset That Led to Breakthroughs | STEIN Fireside PodcastSTEIN Fireside Podcast: Hearing the Brain: How MER Sounds Ep6-Shorts-1Is there a better way to do allergy skin patch testing? | Full episode on channelMayo Clinic Minute - Lighting up lung nodules during surgeryA slam-dunk day as the Minnesota Lynx visit Mayo Clinic ChildrensTomorrows Cure Season 4 Episode 1 Clip: 3D bioprinting at scaleInside Mayo Clinic’s team approach to advanced prostate cancer Part 2 of 9How Modern Science Is Changing Advanced Prostate Cancer | Mayo Clinic Health Matters PodcastCarbon ion therapy: A new era in precision cancer care | Tomorrows Cure Season 5 Episode 1Mayo Clinic in Rochesters Internal Medicine Residency Overview
Mayo Clinic |

Could milk-derived nanoparticles change bile-duct cancer care? | Tomorrow's Cure Season 5 Episode 4

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER